A systematic analysis of BRAF mutations and their sensitivity to different BRAF inhibitors

Press Release Jun 03 2020 Novellus Executes Exclusive Worldwide License Agreement with Plexxikon for PLX8394, Plexxikon’s Next-Generation, Clinical StageBRAF Inhibitor Read more

Press Release Jul 20 2017 New partnership between Christiana Care’s Gene Editing Institute and NovellusDx speeds progress toward personalized cancer medicine Read more

Press Release May 22 2017 NovellusDx Registers Another Patent on their FACT™ system,Publishes a New Study With Guardent Health and MD Anderson InCancer Discovery; Was Selected To Present At BioMed, BIO 2017 andASCO Read more